Premium
Annexon Inc (ANNX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmu... Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -19.8863636364 | 1.76 | 1.83 | 1.285 | 2641914 | 1.51541504 | CS |
| 4 | -1.17 | -45.3488372093 | 2.58 | 3.51 | 1.285 | 2386981 | 2.07504333 | CS |
| 12 | -2.73 | -65.9420289855 | 4.14 | 4.31 | 1.285 | 1601486 | 2.64365878 | CS |
| 26 | -5.56 | -79.7704447633 | 6.97 | 7.85 | 1.285 | 1490312 | 4.22833881 | CS |
| 52 | -4.99 | -77.96875 | 6.4 | 7.85 | 1.285 | 1786045 | 5.07758473 | CS |
| 156 | -1.12 | -44.2687747036 | 2.53 | 8.4 | 1.285 | 1020597 | 4.80430524 | CS |
| 260 | -15.4535 | -91.638746405 | 16.8635 | 38.01 | 1.285 | 734207 | 6.20966859 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
